In the meeting, Sheikh Abdullah Bin Zayed stressed on peace based on 'two-state solution' for Israel and Palestine
uae1 hour ago
The US Food and Drug Administration on Monday added a warning to the fact sheet for Johnson & Johnson's Covid-19 vaccine saying that data suggests there is an increased risk of a rare neurological disorder in the six weeks after inoculation.
In a letter to the company, the FDA classified the chances of getting Guillain-Barré syndrome (GBS) after vaccination as being "very low." Still, it said J&J vaccine recipients should seek medical attention if they have symptoms including weakness or tingling sensations, difficulty walking or difficulty with facial movements.
Around 12.8 million people have received J&J's one-dose vaccine in the United States. The FDA said 100 preliminary reports of GBS in the vaccine recipients include 95 serious cases that required hospitalisation and one reported death.
J&J said in a statement that it was in discussion with regulators about the cases of GBS. It said the rate of reported cases of GBS in J&J vaccine recipients exceeds the background rate only by a small degree.
GBS is a rare neurological condition in which the body's immune system attacks the protective coating on nerve fibers. Most cases follow a bacterial or viral infection. Most people fully recover from GBS.
The condition has been linked in the past to vaccinations - most notably to a vaccination campaign during a swine flu outbreak in the United States in 1976, and decades later to the vaccine used during the 2009 H1N1 flu pandemic.
According to a statement from the US Centers for Disease Control and Prevention (CDC), most of the cases were in men, many of whom were 50 or older.
The warning is another setback for the J&J shot, which was supposed to be an important tool for vaccinating in hard-to-reach areas and among those hesitant to be vaccinated because it requires only one shot and has less stringent storage requirements than the Pfizer or Moderna vaccines.
But use of the vaccine has already been linked to a very rare, potentially life threatening blood clotting condition and slowed by production problems at the main plant where it is being made.
US regulators decided in April that the vaccine's benefits outweighed the risk from the blood clotting issue.
The warning was first reported by the Washington Post on Monday.
In the meeting, Sheikh Abdullah Bin Zayed stressed on peace based on 'two-state solution' for Israel and Palestine
uae1 hour ago
Pakistan have not yet named their final 15-man squad for June's T20 World Cup
cricket1 hour ago
Some riders have also opted to stay home, heeding authorities' advice
weather2 hours ago
Ely Buendia, the band's vocalist and guitarist, shares a teaser of their upcoming shows
entertainment3 hours ago
The prices had slipped below $2,300 per ounce on Wednesday evening but recovered later in the day
uae5 hours ago
Sabeer's story is a blend of facing challenges head on, introducing ideas and demonstrating unwavering determination — all showcasing the strength of resilience and the relentless pursuit of aspirations
kt network5 hours ago
Travellers advised to take extra travel time, keep checking updates
uae5 hours ago
While some devised makeshift rain defences, others who were travelling set out extra early to the airport to catch their flights
uae7 hours ago